Open-label Trial in Parkinson's Disease (PD)
Completed · Phase 3
Conditions studied: Parkinson Disease
In brief
The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease.
Key facts
- Study ID
- NCT04760769
- Run by
- AbbVie
- People needed
- 992
- Starts
- 2021-02-24
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-12-23
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pheonix, Arizona — Phoenix, Arizona, United States
- Little Rock, Arkansas — Little Rock, Arkansas, United States
- Fountain Valley, California — Fountain Valley, California, United States
- Fresno, California — Fresno, California, United States
- Los Angeles, California — Los Angeles, California, United States
- Pasadena, California — Pasadena, California, United States
- Reseda, California — Reseda, California, United States
- Englewood, Colorado — Englewood, Colorado, United States
- Florida, United States — Adventura, Florida, United States
- Boca Raton, Florida — Boca Raton, Florida, United States
- Coral Springs, Florida — Coral Springs, Florida, United States
- Maitland, Florida — Maitland, Florida, United States
- Naples, Florida — Naples, Florida, United States
- Ocala, Florida — Ocala, Florida, United States
- Port Charlotte, Florida — Port Charlotte, Florida, United States
- Port Orange, Florida — Port Orange, Florida, United States
- Tampa, Florida — Tampa, Florida, United States
- Winter Park, Florida — Winter Park, Florida, United States
- Augusta, Georgia — Augusta, Georgia, United States
- Chicago, Illinois — Chicago, Illinois, United States
- Winfield, Illinois — Winfield, Illinois, United States
- Kansas City — Kansas City, Kansas, United States
- Lexington, Kentucky — Lexington, Kentucky, United States
- Scarborough, Maine — Scarborough, Maine, United States
- Birmingham, Alabama — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.